Intraday Screener (Update Freq - 1 Min)   Price/Vol, Pivots, New High    SMA / EMA    Over Bought/Sold   Tech Indicators   Candlestick
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Quarterly Income Statement of Nectar Lifesciences (NECLIFE)

Summary    Balance Sheet    Cash Flow    Income    Qtrly Income    Risk    Profitability    Qtrly Profit    Solvency    

Income Statement of Nectar Lifesciences

Year 30_Sep_2019 30_Jun_2019 30_Sep_2018 30_Jun_2018 31_Mar_2005
Cost Of Revenue 455.12 443.08 586.28 402.36 47.68
Total Revenue/Income 578.35 575.33 723.86 530.77 69.94
Gross Profit 123.23 132.25 137.58 128.40 22.27
Total Operating Expense 544.27 529.74 675.03 486.90 57.13
Other Operating Expense 54.06 50.29 51.63 48.19 48.19
Operating Income/Profit 34.08 45.59 48.83 43.86 12.81
Interest Expense -32.685 -31.470 -43.553 -29.924 -1.852
Net Income From Continuing Operation 2.45 13.70 5.90 13.28 9.66
Depreciation Expense 0 0 0 0 1.46
Total Other Income Expense Net -31.496 -29.342 -42.104 -28.614 -1.941
Net Income 2.45 13.70 5.90 13.28 9.66
Net Income Applicable to Common Share 2.45 13.70 5.90 13.28 9.66
Income/Profit Before Tax 2.59 16.25 6.73 15.25 10.87
Income Tax Expense 0.136 2.55 0.824 1.97 1.22
EBIT 34.08 45.59 48.83 43.86 12.81
EBITDA 35.27 47.72 50.28 45.17 14.18
EPS (Earning Per Share) 0.000 0.000 0.000 0.000 0.877
Total Dividend 0 0 0 0 -0.022

About Financial Data , All results are consolidated, Values are in Crores, Sourced from external Vendors


(All analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)


All Rights Reserved By Mintnovate Market Research Pvt Ltd.